Production scale advantage
Scinosen has the world's first and largest GMP gene pharmaceutical production line, and has gradually developed into a global viral gene pharmaceutical service provider, able to help gene drug developers achieve a complete transition from virtual biotechnology start-ups to large multinational pharmaceutical companies by providing comprehensive end-to-end services.
